On the public citation graph
First– and Second–Line Drugs and Drug Resistance
0 signed · 145 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.280.13.1200-aopenalex-snapshot
The International Journal of Tuberculosis and Lung Disease
inferredcites →https://doi.org/10.1002/j.1460-2075.1989.tb03494.xopenalex-snapshot
Mutations in 16S ribosomal RNA disrupt antibiotic–RNA interactions.
inferredcites →https://doi.org/10.1007/978-3-642-80166-2_3openalex-snapshot
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1007/bf01691135openalex-snapshot
Significance of ahpC Promoter Mutations for the Prediction of Isoniazid Resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1016/0041-3879(85)90040-6openalex-snapshot
The action of antituberculosis drugs in short-course chemotherapy
inferredcites →https://doi.org/10.1016/j.ijantimicag.2007.10.014openalex-snapshot
Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates
inferredcites →https://doi.org/10.1016/j.ijantimicag.2008.09.021openalex-snapshot
Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations
inferredcites →https://doi.org/10.1016/j.molcel.2006.05.044openalex-snapshot
Capreomycin Binds across the Ribosomal Subunit Interface Using tlyA-Encoded 2′-O-Methylations in 16S and 23S rRNAs
inferredcites →https://doi.org/10.1016/s0021-9258(17)31657-5openalex-snapshot
Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria.
inferredcites →https://doi.org/10.1016/s0033-3506(23)80379-1openalex-snapshot
Treatment of tuberculosis
inferredcites →https://doi.org/10.1016/s0171-2985(11)80466-3openalex-snapshot
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1016/s1201-9712(02)90136-0openalex-snapshot
Characterization of pyrazinamide and ofloxacin resistance among drug-resistant Mycobacterium tuberculosis isolates from Singapore
inferredcites →https://doi.org/10.1016/s1473-3099(03)00671-6openalex-snapshot
Fluoroquinolones, tuberculosis, and resistance
inferredcites →https://doi.org/10.1038/358591a0openalex-snapshot
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1038/nm0597-567openalex-snapshot
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
inferredcites →https://doi.org/10.1038/nm0696-662openalex-snapshot
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
inferredcites →https://doi.org/10.1038/nsmb.1755openalex-snapshot
The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome
inferredcites →https://doi.org/10.1054/tuld.1998.0002openalex-snapshot
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
inferredcites →https://doi.org/10.1056/nejm200104263441706openalex-snapshot
Global Trends in Resistance to Antituberculosis Drugs
inferredcites →https://doi.org/10.1073/pnas.0907925106openalex-snapshot
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1073/pnas.93.21.11919openalex-snapshot
The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.
inferredcites →https://doi.org/10.1073/pnas.97.17.9677openalex-snapshot
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1086/313954openalex-snapshot
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
inferredcites →https://doi.org/10.1086/507542openalex-snapshot
Extensively Drug‐Resistant Tuberculosis: 2 Years of Surveillance in Iran
inferredcites →https://doi.org/10.1093/infdis/119.3.317openalex-snapshot
Infectious Diseases Society of America
inferredcites →https://doi.org/10.1093/infdis/167.6.1505openalex-snapshot
A Ribosomal Gene Mutation in Streptomycin-ResistantMycobacterium tuberculosis Isolates
inferredcites →https://doi.org/10.1093/jac/dkq202openalex-snapshot
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1093/jac/dkr109openalex-snapshot
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1093/jac/dkr173openalex-snapshot
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
inferredcites →https://doi.org/10.1097/00000446-192905000-00034openalex-snapshot
American Review of Tuberculosis
inferredcites →https://doi.org/10.1097/00019048-200101000-00016openalex-snapshot
PRACTICE GUIDELINES FOR MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
inferredcites →https://doi.org/10.1099/00221287-144-9-2539openalex-snapshot
Mechanism of isoniazid uptake in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1111/j.1365-2672.2010.04840.xopenalex-snapshot
Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs
inferredcites →https://doi.org/10.1111/j.1365-2958.1993.tb00924.xopenalex-snapshot
The rpsL gene and streptomycin resistance in single and multiple drug‐resistant strains of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1111/j.1365-2958.1993.tb01253.xopenalex-snapshot
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot
inferredcites →https://doi.org/10.1111/j.1365-2958.1995.tb02238.xopenalex-snapshot
Missense mutations in the catalase‐peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1111/j.1365-2958.2004.04120.xopenalex-snapshot
The folate pathway is a target for resistance to the drug para‐aminosalicylic acid (PAS) in mycobacteria
inferredcites →https://doi.org/10.1111/j.1365-2958.2006.05585.xopenalex-snapshot
Loss of a conserved 7‐methylguanosine modification in 16S rRNA confers low‐level streptomycin resistance in bacteria
inferredcites →https://doi.org/10.1111/j.1469-0691.2009.03078.xopenalex-snapshot
Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan
inferredcites →https://doi.org/10.1126/science.272.5268.1641openalex-snapshot
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1126/science.8284673openalex-snapshot
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/9781555818845openalex-snapshot
Molecular Genetics of Mycobacteria
inferredcites →https://doi.org/10.1128/aac.00110-08openalex-snapshot
Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.00112-06openalex-snapshot
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.00851-09openalex-snapshot
High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs Gene
inferredcites →https://doi.org/10.1128/aac.00944-06openalex-snapshot
Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones
inferredcites →https://doi.org/10.1128/aac.01288-09openalex-snapshot
Allelic Exchange and Mutant Selection Demonstrate that Common Clinical embCAB Gene Mutations Only Modestly Increase Resistance to Ethambutol in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.01570-07openalex-snapshot
Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism
inferredcites →https://doi.org/10.1128/aac.33.9.1493openalex-snapshot
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
inferredcites →https://doi.org/10.1128/aac.37.10.2054openalex-snapshot
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis
inferredcites →https://doi.org/10.1128/aac.38.2.238openalex-snapshot
Streptomycin resistance in mycobacteria
inferredcites →https://doi.org/10.1128/aac.38.4.773openalex-snapshot
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations
inferredcites →https://doi.org/10.1128/aac.39.8.1700openalex-snapshot
Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients
inferredcites →https://doi.org/10.1128/aac.40.5.1186openalex-snapshot
Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City
inferredcites →https://doi.org/10.1128/aac.40.8.1768openalex-snapshot
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra
inferredcites →https://doi.org/10.1128/aac.41.10.2270openalex-snapshot
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
inferredcites →https://doi.org/10.1128/aac.41.3.540openalex-snapshot
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.41.8.1677openalex-snapshot
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
inferredcites →https://doi.org/10.1128/aac.43.7.1761openalex-snapshot
Characterization of New Mutations in Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Identification of Conserved Regions Important for the Catalytic Activity of the Pyrazinamidase PncA
inferredcites →https://doi.org/10.1128/aac.44.2.326-336.2000openalex-snapshot
Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Ethambutol Resistance in Human Isolates of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.44.3.528-532.2000openalex-snapshot
pncA Mutations as a Major Mechanism of Pyrazinamide Resistance in Mycobacterium tuberculosis : Spread of a Monoresistant Strain in Quebec, Canada
inferredcites →https://doi.org/10.1128/aac.44.4.1075-1077.2000openalex-snapshot
Mutations in the Beginning of the rpoB Gene Can Induce Resistance to Rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.48.11.4447-4449.2004openalex-snapshot
Novel Mutations within the embB Gene in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.48.2.596-601.2004openalex-snapshot
Multiplex PCR Amplimer Conformation Analysis for Rapid Detection of gyrA Mutations in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates
inferredcites →https://doi.org/10.1128/aac.49.8.3192-3197.2005openalex-snapshot
Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.50.3.1075-1078.2006openalex-snapshot
Molecular Characterization of Isoniazid Resistance in Mycobacterium tuberculosis : Identification of a Novel Mutation in inhA
inferredcites →https://doi.org/10.1128/cmr.8.4.496openalex-snapshot
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
inferredcites →https://doi.org/10.1128/jcm.00081-09openalex-snapshot
Feasibility of the GenoType MTBDR sl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
inferredcites →https://doi.org/10.1128/jcm.00330-06openalex-snapshot
Mutations Prevalent among Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Isolates from a Hospital in Vietnam
inferredcites →https://doi.org/10.1128/jcm.01476-09openalex-snapshot
Polymorphisms Associated with Resistance and Cross-Resistance to Aminoglycosides and Capreomycin in Mycobacterium tuberculosis Isolates from South Korean Patients with Drug-Resistant Tuberculosis
inferredcites →https://doi.org/10.1128/jcm.40.10.3810-3813.2002openalex-snapshot
Detection of embB306 Mutations in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis from Northwestern Russia: Implications for Genotypic Resistance Testing
inferredcites →https://doi.org/10.1128/jcm.40.2.501-507.2002openalex-snapshot
Rapid Detection of Pyrazinamide-Resistant Mycobacterium tuberculosis by a PCR-Based In Vitro System
inferredcites →https://doi.org/10.1136/thx.2005.056887openalex-snapshot
Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas
inferredcites →https://doi.org/10.1146/annurev.bi.53.070184.001003openalex-snapshot
STRUCTURE OF RIBOSOMAL RNA
inferredcites →https://doi.org/10.1164/arrd.1967.95.3.461openalex-snapshot
Pyrazinamide susceptibility and amidase activity of tubercle bacilli.
inferredcites →https://doi.org/10.1164/art.1952.65.4.357openalex-snapshot
Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds.
inferredcites →https://doi.org/10.1164/art.1954.69.3.471openalex-snapshot
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
inferredcites →https://doi.org/10.1164/art.1954.70.4.748openalex-snapshot
Activation of pyrazinamide and nicotinamide in acidic environments in vitro.
inferredcites →https://doi.org/10.1183/09031936.00028708openalex-snapshot
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
inferredcites →https://doi.org/10.1183/09031936.00073611openalex-snapshot
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
inferredcites →https://doi.org/10.1186/1471-2334-1-4openalex-snapshot
pncA mutations in clinical Mycobacterium tuberculosisisolates from Korea
inferredcites →https://doi.org/10.1186/rr54openalex-snapshot
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1378/chest.76.6.771openalex-snapshot
Basic Mechanisms of Chemotherapy
inferredcites →https://doi.org/10.3201/eid1411.080729openalex-snapshot
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
inferredcites →https://doi.org/10.5694/j.1326-5377.1975.tb105896.xopenalex-snapshot
THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
inferredcites →https://doi.org/10.5772/54960openalex-snapshot
First– and Second–Line Drugs and Drug Resistance
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.71.e118795zenodo-depositor-declared
Evaluation of therapeutic effectiveness of antituberculosis injection based on conversion time in drug-resistant tuberculosis
inferred← citeshttps://doi.org/10.1007/s00706-021-02806-7openalex-snapshot
Fluoroquinolones: a review on anti-tubercular activity
inferred← citeshttps://doi.org/10.1007/s11033-022-08158-7openalex-snapshot
Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury
inferred← citeshttps://doi.org/10.1007/s12013-016-0764-3openalex-snapshot
Sliding Clamp of DNA Polymerase III as a Drug Target for TB Therapy: Comprehensive Conformational and Binding Analysis from Molecular Dynamic Simulations
inferred← citeshttps://doi.org/10.1007/s12013-018-0852-7openalex-snapshot
Induced Mutation Proves a Potential Target for TB Therapy: A Molecular Dynamics Study on LprG
inferred← citeshttps://doi.org/10.1007/s40203-021-00086-xopenalex-snapshot
Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-814423-7.00021-6openalex-snapshot
Impact of Pharmaceutical Product Quality on Clinical Efficacy
inferred← citeshttps://doi.org/10.1016/b978-0-323-41533-0.00011-8openalex-snapshot
Designing and testing single tablet for tuberculosis treatment through electrospinning
inferred← citeshttps://doi.org/10.1016/j.ab.2017.12.031openalex-snapshot
Automated real-time detection of drug-resistant Mycobacterium tuberculosis on a lab-on-a-disc by Recombinase Polymerase Amplification
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.03.048openalex-snapshot
Dibenzofuran, dibenzothiophene and N-methyl carbazole tethered 2-aminothiazoles and their cinnamamides as potent inhibitors of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2018.11.007openalex-snapshot
Computational studies on N-phenyl pyrrole derivatives as MmpL3 inhibitors in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.111343openalex-snapshot
In silico identification of potential inhibitors of Mycobacterium tuberculosis DNA gyrase from Phytoconstituents of Indian medicinal plants
inferred← citeshttps://doi.org/10.1016/j.csbj.2020.05.009openalex-snapshot
Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.12.043openalex-snapshot
Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ijtb.2026.04.014openalex-snapshot
Prevalence of fluoroquinolone resistance in treatment naive tuberculosis patients
inferred← citeshttps://doi.org/10.1016/j.jctube.2023.100379openalex-snapshot
Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.lfs.2024.122632openalex-snapshot
Synchronization of Mycobacterium life cycle: A possible novel mechanism of antimycobacterial drug resistance evolution and its manipulation
inferred← citeshttps://doi.org/10.1016/j.micpath.2017.09.055openalex-snapshot
Adaptive gene profiling of Mycobacterium tuberculosis during sub-lethal kanamycin exposure
inferred← citeshttps://doi.org/10.1016/j.sciaf.2025.e02627openalex-snapshot
Investigating the evolutionary dynamics of second-line Mycobacterium tuberculosis drug resistance in Tanzania using hypercubic modelling and the Baum–Welch algorithm
inferred← citeshttps://doi.org/10.1016/j.tube.2020.101987openalex-snapshot
Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis
inferred← citeshttps://doi.org/10.1016/s2666-5247(24)00022-3openalex-snapshot
Identification of bacterial determinants of tuberculosis infection and treatment outcomes: a phenogenomic analysis of clinical strains
inferred← citeshttps://doi.org/10.1039/d3ra03862aopenalex-snapshot
Recent advances in the synthesis of new benzothiazole based anti-tubercular compounds
inferred← citeshttps://doi.org/10.1073/pnas.1721545115openalex-snapshot
Plasticity of Mycobacterium tuberculosis NADH dehydrogenases and their role in virulence
inferred← citeshttps://doi.org/10.1080/00397911.2019.1614630openalex-snapshot
Synthesis, antitubercular evaluation and molecular docking studies of phthalimide bearing 1,2,3-triazoles
inferred← citeshttps://doi.org/10.1080/07391102.2020.1719205openalex-snapshot
Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1080/15569543.2020.1818105openalex-snapshot
Toxins mechanism in instigating hepatotoxicity
inferred← citeshttps://doi.org/10.1093/bioinformatics/bty949openalex-snapshot
Application of machine learning techniques to tuberculosis drug resistance analysis
inferred← citeshttps://doi.org/10.1093/jacamr/dlag007openalex-snapshot
Within-host evolution of drug tolerance in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1101/2023.04.09.536166openalex-snapshot
High-throughput phenogenotyping of Mycobacteria tuberculosis clinical strains reveals bacterial determinants of treatment outcomes
inferred← citeshttps://doi.org/10.1101/2025.09.19.677270openalex-snapshot
The C3HeB/FeJ Kramnik mouse as a model to investigate the efficacy of therapeutic tuberculosis interventions
inferred← citeshttps://doi.org/10.1109/wccs62745.2024.10765528openalex-snapshot
Advanced Machine Learning for Predicting Drug Resistance in Clinical Isolates of Mycobacterium Tuberculosis Complex
inferred← citeshttps://doi.org/10.1111/cbdd.13865openalex-snapshot
A consequence of drug targeting of aminoacyl‐tRNA synthetases in Mycobacteriumtuberculosis
inferred← citeshttps://doi.org/10.1128/spectrum.00615-21openalex-snapshot
Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment
inferred← citeshttps://doi.org/10.1186/s12859-018-2403-zopenalex-snapshot
Predicting bacterial resistance from whole-genome sequences using k-mers and stability selection
inferred← citeshttps://doi.org/10.1186/s12859-019-3045-5openalex-snapshot
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS)
inferred← citeshttps://doi.org/10.1186/s12859-020-03762-5openalex-snapshot
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB
inferred← citeshttps://doi.org/10.1186/s13690-022-00807-4openalex-snapshot
Tuberculosis poor treatment outcomes and its determinants in Kilifi County, Kenya: a retrospective cohort study from 2012 to 2019
inferred← citeshttps://doi.org/10.1186/s40169-018-0208-3openalex-snapshot
Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti‐tuberculosis activity
inferred← citeshttps://doi.org/10.1371/journal.pone.0217457openalex-snapshot
A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies
inferred← citeshttps://doi.org/10.18203/2319-2003.ijbcp20195788openalex-snapshot
Ethambutol induced optic neuritis: a case series
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4000354/v1openalex-snapshot
Study and implementation of a new machine learning algorithm to predict drug resistance in Mycobacterium tuberculosis complex clinical isolates
inferred← citeshttps://doi.org/10.21203/rs.3.rs-966867/v1openalex-snapshot
Tuberculosis Poor Treatment Outcomes and its determinants in Kilifi County, Kenya: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.22207/jpam.19.4.38openalex-snapshot
Characterization of Second-Line Drug-resistance Mutations in Multidrug-resistant Mycobacterium tuberculosis Isolates of Andhra Pradesh, India
inferred← citeshttps://doi.org/10.3389/fmicb.2025.1586476openalex-snapshot
Feature selection and aggregation for antibiotic resistance GWAS in Mycobacterium tuberculosis: a comparative study
inferred← citeshttps://doi.org/10.3389/frmbi.2023.1123064openalex-snapshot
Gut microbiome variation in pulmonary TB patients with diabetes or HIV comorbidities
inferred← citeshttps://doi.org/10.3390/app13085008openalex-snapshot
Are Plants Used as a Combating Strategy against Tuberculosis in the Mpumalanga Province, South Africa?
inferred← citeshttps://doi.org/10.3390/ijms23041964openalex-snapshot
Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain
inferred← citeshttps://doi.org/10.3390/ijms24043383openalex-snapshot
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles
inferred← citeshttps://doi.org/10.3390/molecules25071561openalex-snapshot
5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
inferred← citeshttps://doi.org/10.3390/molecules25133011openalex-snapshot
The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives
inferred← citeshttps://doi.org/10.3390/pathogens10050607openalex-snapshot
Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains
inferred← citeshttps://doi.org/10.4018/978-1-7998-5049-6.ch004openalex-snapshot
Nanomedicine and Its Applications in Combating Resistance Relating to Opportunistic Pathogens With Special Reference to Tuberculosis
inferred← citeshttps://doi.org/10.4314/ijbcs.v14i9.14openalex-snapshot
Evaluation of antimycobacterial activity of medicinal plants used by Malian traditional medicine practitioners to treat tuberculosis
inferred← citeshttps://doi.org/10.4314/tjpr.v15i1.28openalex-snapshot
Nanoformulations and Clinical Trial Candidates as Probably Effective and Safe Therapy for Tuberculosis
inferred← citeshttps://doi.org/10.54250/ijls.v5i01.172openalex-snapshot
Drug-Resistant Pulmonary Tuberculosis
inferred← citeshttps://doi.org/10.58837/chula.the.2020.1041openalex-snapshot
การพฒนาเทคนค Multiplex allele specific-polymerase chain reaction รวมกบแผนทดสอบ Dipstick chromatography เพอใชวนจฉยการกลายพนธของยน katG และยน inhA ทสมพนธกบการดอยา Isoniazid ของเชอ Mycobacterium tuberculosis
showing the first 57 of 58 · page through all 58
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.